Juluca FDA Approval History
FDA Approved: Yes (First approved November 21, 2017)
Brand name: Juluca
Generic name: dolutegravir and rilpivirine
Dosage form: Tablets
Company: ViiV Healthcare
Treatment for: HIV Infection
Juluca (dolutegravir and rilpivirine) is a single-tablet, two-drug regimen of the approved drugs dolutegravir (Tivicay) and rilpivirine (Edurant) for the maintenance treatment of virologically suppressed HIV-1 infection.
Development timeline for Juluca
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.